medigraphic.com
Instituto Nacional de Salud Pública

2005, Number 6

<< Back Next >>

salud publica mex 2005; 47 (6)

Costs of medical care attributable to tobacco consumption at the Mexican Institute of Social Security (IMSS), Morelos.

Reynales-Shigematsu LM, Juárez-Márquez SA, Valdés-Salgado R

Language: Spanish
References: 34
Page: 451-457
PDF size: 131.67 Kb.


ABSTRACT

Objective. To estimate the cost of medical care for the major diseases attributable to tobacco consumption at the IMSS, Morelos. Material and Methods. A cost of illness (COI) analysis was carried out from the perspective of the health provider. An expert panel characterized medical care in primary and secondary care levels according to severity of disease. The smoking attributable fraction (SAF) by disease was used to derive costs attributable to tobacco consumption. The unitary cost was valuated in 2001 Mexican pesos (MP). Results. The estimated annual average cost of medical care (diagnosis and first year of treatment) was 79 530 MP for acute myocardial infarction (AMI); 73 303 MP for chronic obstructive pulmonary disease (COPD); and 102 215 MP for lung cancer (LC). The annual total cost of medical care for IMSS was 147 390 688 MP. The total annual cost of medical care attributable to tobacco consumption corresponds to $124 million MP, which is equivalent to 7.3% of the annual budget of the Morelos Delegation. Conclusions. These results confirm the high medical costs associated with smoking. A repetition of this study at the national level is recommended in order to support decision-makers in strengthening public policies to control tobacco use in Mexico.


REFERENCES

  1. U.S Department of Health, Education and Welfare (USDHEW). Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington, D.C: U.S. Government Printing office: DHEW publication No. (PHS) 1103, 1964.

  2. U.S Department of Health and Human Services (USDHHS). The Health Consequences of Smoking: Cancer. A Report of the Surgeon General, Washington, D.C: U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health, DHHS Publication No. (PHS) 82-50179, 1982.

  3. U.S Department of Health and Human Services (USDHHS). The Health General. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health, DHHS Publication No. (PHS) 84–50204, 1983.

  4. Great Britain Scientific Committee on Tobacco and Health Great Britain Department of Health Scientific Committee on Tobacco and Health. Report of the Scientific Committee on Tobacco and Health. Pitman Medical Publishing Co., LTD London, 1988.

  5. Samet J. Los riesgos del tabaquismo activo y pasivo. Salud Publica Mex 2002; 44 (SI): S144-S160.

  6. US Department of Health and Human Services (USDHHS). The health consequences of smoking: A Report of the Surgeon General. Atlanta (GA): US Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.

  7. The World Bank. Curbing the epidemic: Governments and Economics of Tobacco Control. Washington, DC: World Bank, 1999.

  8. SSA-CONADIC. Encuesta Nacional de Adicciones 2002: Alcohol, tabaco y otras drogas. Resumen Ejecutivo, México, SSA-CONADIC, 2002

  9. INEGI-SSA. Estadísticas de mortalidad en México: Muertes registradas en el año 2000. Salud Publica Mex 2002; 44 : 266-282.

  10. Valdés-Salgado R. Las cifras de la epidemia. Daños a la salud y mortalidad atribuible. En: Primer informe sobre combate al tabaquismo. México ante el Convenio Marco para el Control del Tabaco. México. Cuernavaca: Instituto Nacional de Salud Pública, 2005:29-41.

  11. Hodgson TA, Meiners MR. Cost-of-illness methodology: A guide to current practices and procedures. Milbank Mem Fund Q 1982; 60:429-462.

  12. MacKenzie T, Bartecchi C, Schier R. The human costs of tobacco use. N Engl J Med 1994; 330: 975–980.

  13. Barendregt JJ, Bonneu L, Van Der Mass PJ. The health care costs of smoking. N Engl J Med 1997; 337:1052-1057.

  14. Warner K, Hodgson TA, Carroll C. Medical cost of smoking in the United States: Estimates, their validity, and their implications. Tob control 1999; 8:290-300.

  15. Leistikow B. The Human and Financial Costs of smoking. En: Smoking and Pulmonary and Cardiovascular Diseases. Clinics Chest Medicine 2000; 21:189-195.

  16. Lightwood J, Collins D, Lapsley H, Novotny T. Estimating the costs of tobacco use. Tobacco control in developing countries. Editors Jha P and Chaloupka F. Nueva York: Oxford University Press, 2000:63-99.

  17. Single E, Collins D, Easton B, Harwood H, Lapsley H, Kopp P et al. International Guidelines for estimating the Costs of Substance Abuse. Second Edition. Toronto, 2001.

  18. Jones J, Hunter D. Qualitative Research: Consensus methods for medical and health services research. BMJ 1995; 311:376-380.

  19. Pagliari C et al. The potential influence of small group processes on guide line development. J Eval Clin Pract 2001; 7: 165-173.

  20. IMSS. Guías Diagnóstico–Terapéuticas: IAM, EPOC, CP. Cuernavaca, Morelos, 2001. (Documento interno del IMSS)

  21. IMSS. Dirección de Planeación y Finanzas. Coordinación de presupuesto, contabilidad y evaluación financiera. Metodología de costeo “Presupuesto Capitado”, Instructivo para su uso. Ciudad de México, México, 2000. (Documento Interno del IMSS).

  22. Drummond M, O´Brien B, Stoddart G, Torrance G. Métodos para la evaluación económica de los programas de asistencia sanitaria. Segunda edición. Madrid: Ediciones Díaz de Santos, 2001.

  23. Castaño S. Cómo calcular sus costos. Guía para profesionales de la salud. Centro de Gestión Hospitalaria. Bogotá, Colombia, 1997.

  24. RITC. At what cost? The economic impact of tobacco use on national health systems, societies and individuals: A summary of methods and findings. Monographs series No. 1, Otawa, 2003.

  25. Rothman K, Greenland S. Modern epidemiology; 2nd ed. Hagerstown: Lippincott-Raven, 1997

  26. Szklo M, Nieto J. Epidemiology: Beyond the basics. Gaithersburg, Maryland: Aspen Publisher Inc, 2000.

  27. Salazar E, Sánchez L, López L, Estrada A, Lazcano E, Hernández M. El tabaquismo y su fracción atribuible en la enfermedad isquémica cardiaca. Salud Publica Mex 2002; 44, (SI): S34-S43.

  28. Kuritz S, Landis J. Attributable risk estimation from matched case control data. Biometrics 1998; 14 7:250-258.

  29. CDC, Smoking-attributable mortality, morbidity and economic cost, SAMMEC [ sitio de internet] Disponible en: http://apps.nccd.cdc.gov/sammec/login.asp.

  30. Murphy MK et al. Consensus development methods and their use in clinical guideline development. Health Technol Assess 1998; 2 y 3.

  31. Hodgson TA, Sinsheimer P, Browner W, Kopstein AN. The economic costs of the health effects of smoking, 1984. Rice DP. Milbank Q 1986; 64 (4):489–547.

  32. Miller LS, Zhang X, Rice DP. State estimates of total medical expenditures attributable to cigarette smoking, 1993. Public Health Rep 1998; 113: 447-458.

  33. Miller VP, Ernst C, Collin F. Smoking-attributable medical care costs in the USA. Soc Sci Med 1999; 48: 375-391.

  34. Caraballo R, Lee C. Consumo de tabaco entre los mexicanos y sus descendientes en Estados Unidos de América. Salud Publica Mex 2004; 46 (3): 241-250.




2020     |     www.medigraphic.com